多重耐药和广泛耐药鲍曼不动杆菌感染治疗的药物选择

张驰1; 2; 凌保东1; 2

doi:10.3969/j.issn.1673-6184.2018.02.005

PDF(700 KB)

微生物与感染 ›› 2018, Vol. 13 ›› Issue (2) : 90-96. DOI: 10.3969/j.issn.1673-6184.2018.02.005

综述

多重耐药和广泛耐药鲍曼不动杆菌感染治疗的药物选择

张驰^1,2，凌保东^1,2

作者信息 +

Treatment options for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections

ZHANG Chi^1,2, LING Baodong^1,2

Author information +

文章历史 +

摘要

鲍曼不动杆菌是医院内感染的重要病原体，其基于内在性和获得性的耐药机制，导致全球抗感染领域面临巨大挑战。目前，针对多重耐药和广泛耐药鲍曼不动杆菌引起的感染尚无有效治疗方案，本文对其可选用的治疗药物及最新进展进行综述。

Abstract

Acinetobacter baumannii (A. baumannii) is the major pathogen causing nosocomial infectious diseases in the world due to various intrinsic and acquired mechanisms of drug resistance. There are no effective treatments for the infections caused by multidrug-resistant A. baumannii and extensively-resistant A. baumannii. This review lists standard drugs and new options for the treatment.

导出引用

张驰1,2，凌保东1,2. 多重耐药和广泛耐药鲍曼不动杆菌感染治疗的药物选择[J]. 微生物与感染. 2018, 13(2): 90-96 https://doi.org/10.3969/j.issn.1673-6184.2018.02.005

ZHANG Chi1,2, LING Baodong1,2. Treatment options for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections[J]. Journal of Microbes and Infections. 2018, 13(2): 90-96 https://doi.org/10.3969/j.issn.1673-6184.2018.02.005